Winter 2022/2023 Vol. 12 Issue 04
-
From the Editor-in-Chief
Taking Aim at Cancer
Therapeutic antibodies carry ‘payloads’ to destroy cancer cells.
by William G. Nelson, MD, PhD
-
Your Cancer Guide
Finding Light in Winter’s Darkness
Colder temperatures, gray skies and shorter days can dampen the spirits, which can heighten sadness associated with cancer treatment.
by Hester Hill Schnipper
-
Caregiving With Confidence
Creating Calm in Chaos
A prepacked bag of essential and not-so-essential items can provide structure and comfort to people with cancer during treatment.
by K.J. Bannan
-
Policy Matters
Stemming the E-Cigarette Epidemic
An updated AACR-ASCO joint statement recommends steps for policymakers to lower e-cigarette use among youth and young adults.
by Roy S. Herbst, MD, PhD
-
Cervical Cancer: A Global Challenge
Low- and middle-income countries make inroads against a preventable and treatable cancer.
by Erin O’Donnell
-
Mysterious Microbes
Scientists look to decode the role of intestinal bacteria in our responses to immunotherapy.
by Natalie Slivinski
-
An Ongoing Discussion
Physicians are often hesitant to bring up end-of-life care discussions with their patients. People being treated for cancer may need to frame questions to determine their own goals of care.
by Cameron Walker
-
Survivor Profile
Rising to the Challenge
James R. Scott uses his experiences with bladder cancer to be a light for others.
by Lindsey Konkel Neabore
-
Q&A
The FDA’s Risk-Benefit Framework
Using the withdrawal of Avastin’s approval for breast cancer as a case study, Mikkael A. Sekeres’ new book analyzes the U.S. drug approval process.
by Marci A. Landsmann
-
Get Involved
Healing Takes Flight
Alicia and Esther Tambe honor their sister’s memory by providing travel experiences to Black women diagnosed with breast cancer.
by Thomas Celona
-
Facts and Stats
Setting the Stage
Understanding your cancer’s stage is important for determining your prognosis and treatment options. Here’s what the different stages mean.
by Thomas Celona
Cancer Talk
Lesbians, bisexual women and transgender men had a longer wait for diagnosis and a higher risk of recurrence.
by Jon Kelvey
Deconstructing Peripheral Neuropathy and Chemo BrainResearchers explore mechanisms of chemotherapy-related neurotoxicity at the AACR Annual Meeting 2023.
by Marci A. Landsmann
AACR Annual Meeting 2023Catch up on all of Cancer Today's coverage from the AACR Annual Meeting 2023.
More Prostate Cancer Patients Choose SurveillanceMen are increasingly opting to put off treatment for low-risk prostate cancer, and doctors say it’s a good thing.
by Kyle Bagenstose